37966311000001106: Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)
\UK product\Virtual medicinal product\Abacavir 600mg / Lamivudine 300mg tablets\Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)
\UK product\Virtual therapeutic moiety\Abacavir + Lamivudine\Abacavir 600mg / Lamivudine 300mg tablets\Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing reverse transcriptase inhibitor\Product containing abacavir\Product containing abacavir and lamivudine\Abacavir + Lamivudine\Abacavir 600mg / Lamivudine 300mg tablets\Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing reverse transcriptase inhibitor\Product containing lamivudine\Product containing abacavir and lamivudine\Abacavir + Lamivudine\Abacavir 600mg / Lamivudine 300mg tablets\Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing pyrimidine\Product containing lamivudine\Product containing abacavir and lamivudine\Abacavir + Lamivudine\Abacavir 600mg / Lamivudine 300mg tablets\Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)
\Medicinal product\Medicinal product categorized by structure\Product containing nucleoside analog\Product containing abacavir\Product containing abacavir and lamivudine\Abacavir + Lamivudine\Abacavir 600mg / Lamivudine 300mg tablets\Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)
\Medicinal product\Medicinal product categorized by structure\Product containing nucleoside analog\Product containing lamivudine\Product containing abacavir and lamivudine\Abacavir + Lamivudine\Abacavir 600mg / Lamivudine 300mg tablets\Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing abacavir\Product containing abacavir and lamivudine\Abacavir + Lamivudine\Abacavir 600mg / Lamivudine 300mg tablets\Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing lamivudine\Product containing abacavir and lamivudine\Abacavir + Lamivudine\Abacavir 600mg / Lamivudine 300mg tablets\Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Feb 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

1173281000001110 Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1173291000001112 Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)	Is a	Abacavir 600mg / Lamivudine 300mg tablets	true	Inferred relationship	Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)	Has excipient	Polysorbate	false	Inferred relationship	Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)	Is a	Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet	false	Inferred relationship	Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)	Has specific active ingredient	Abacavir	true	Inferred relationship	Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)	Has specific active ingredient	Lamivudine	true	Inferred relationship	Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Abacavir	false	Inferred relationship	Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)	Is a	Abacavir 600mg / Lamivudine 300mg tablets	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.) 30 tablet	Has AMP	True	Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1173281000001110	Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
1173291000001112	Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module